Citations

Mayo Clinic

Showing 10 of 108490 citations.

Hyaluronan: Is Bigger Better?
Camenisch, Todd D. , McDonald, John A.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 23 | Issue: 4 | Pages: 431-433

10.1165/ajrcmb.23.4.f201 | PMID 11017905 Get It

Phosphatidylinositol Kinase Regulation of Airway Smooth Muscle Cell Proliferation
Thomas, Charles F., Limper, Andrew H.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 23 | Issue: 4 | Pages: 429-430

10.1165/ajrcmb.23.4.f200 | PMID 11017904 Get It

Pneumocystis carinii Uses a Functional Cdc13 B-Type Cyclin Complex during Its Life Cycle
Thomas, Charles F., Mubarak, Kamal K., Leof, Edward B. , Kottom, Theodore J. , Limper, Andrew H.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 22 | Issue: 6 | Pages: 722-731

10.1165/ajrcmb.22.6.3838 | PMID 10837370 Get It

Abstract Pneumocystis carinii causes severe pneumonia in immunocompromised patients. Recent studies indicate that P. carinii uses a Cdc2 cyclin-dependent kinase to control its proliferation. To further study the regulation of the life cycle of P. carinii, we characterized the P. carinii B-type cyclin termed Cdc13, whose binding to Cdc2 is necessary for kinase activity. Antibodies to B-type cyclins (Cdc13) specifically immunoprecipitated Cdc2/Cdc13 complexes with associated kinase activity from P. carinii extracts. To clone P. carinii cdc13, degenerate polymerase chain reaction was undertaken using primers generated from amino-acid motifs conserved in fungal Cdc13 proteins. This amplicon was used to obtain full-length genomic and complementary DNA (cDNA) clones. A specific synthetic peptide antibody generated to P. carinii Cdc13 further demonstrated differential Cdc2/Cdc13 activity over the life cycle of P. carinii, with greater activity in cysts compared with trophic forms of the organism. Finally, P. carinii cdc13 cDNA was used to rescue mutant Schizosaccharomyces pombe strains containing temperature-sensitive deficiencies of endogenous Cdc13 activity, thus verifying function of the P. carinii Cdc13 protein. Therefore, P. carinii contains a Cdc13 cyclin, which is variably active over its life cycle and which promotes fungal proliferation.
Vitronectin and Fibronectin Function as Glucan Binding Proteins Augmenting Macrophage Responses to Pneumocystis carinii
Vassallo, Robert , Standing, Joseph E., Kottom, Theodore J. , Limper, Andrew H. , Vassallo, Robert

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 25 | Issue: 2 | Pages: 203-211

10.1165/ajrcmb.25.2.4427 | PMID 11509330 Get It

Abstract β -glucans represent major structural components of fungal cell walls. We recently reported that Pneumocystis carinii β -glucans stimulate alveolar macrophages to release proinflammatory cytokines. Macrophage activation by β -glucan is augmented by serum, implying the presence of circulating factors that interact with β -glucans and enhance their ability to stimulate macrophages. Using β -glucan–enriched cell wall fractions from P. carinii and Saccharomyces cerevisiae, two prominent proteins were precipitated from serum and demonstrated to be vitronectin (VN) and fibronectin (FN) by immune analysis. Preincubation of β -glucan with VN or FN enhanced macrophage activation in response to this cell wall component. Because VN and FN accumulate in the lungs during P. carinii pneumonia, we further investigated hepatic and pulmonary expression of VN and FN messenger RNA during infection. P. carinii pneumonia in rodents is associated with increased hepatic expression of VN and FN as well as increased local expression of FN in the lung. Because interleukin (IL)-6 represents the major regulator of VN and FN expression during inflammatory conditions, we measured macrophage IL-6 release in response to stimulation with P. carinii β -glucan. Stimulation of macrophages with P. carinii β -glucan induced significant release of IL-6. Elevated concentrations of IL-6 were noted in the blood of infected animals compared with uninfected control animals. These studies indicate that VN and FN bind to β -glucan components of P. carinii and augment macrophage inflammatory responses. P. carinii cell wall β -glucan stimulates secretion of IL-6 by macrophages, thereby enhancing hepatic synthesis of both VN and FN, and lung synthesis of FN during pneumonia.
Carbohydrate Recognition Domain of Surfactant Protein D Mediates Interactions with Pneumocystis carinii Glycoprotein A
Vuk-Pavlović, Zvezdana, Standing, Joseph E., Crouch, Erika C., Limper, Andrew H.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 24 | Issue: 4 | Pages: 475-484

10.1165/ajrcmb.24.4.3504 | PMID 11306442 Get It

Abstract Pneumocystis carinii continues to cause severe pneumonia in immunocompromised patients. Surfactant protein D (SP-D), a lung collectin, markedly accumulates during P. carinii pneumonia and binds to glycoprotein A (gpA) on the surface of P. carinii, thereby enhancing interactions with alveolar macrophages. Herein, we report the structural basis of the interaction of SP-D with gpA. We demonstrate that natural SP-D binds to purified gpA in the presence of 2 mM calcium in a saturable, concentration-dependent manner, which is abolished by 10 mM ethylenediaminetetraacetic acid. Increasing concentrations of calcium under otherwise cation-free conditions significantly enhance SP-D binding to gpA, whereas manganese and magnesium cations have minimal effect. Maximal SP-D binding occurs at pH 7.4, with significant inhibition at pH 4. SP-D binding to gpA is also competitively inhibited by maltose > glucose > mannose > N-acetyl-glucosamine. Comparison of the binding of various natural and recombinant forms of SP-D to gpA reveals that the number of carbohydrate recognition domains (CRDs) in a given SP-D form determines the relative extent of binding to gpA. Maximal binding is observed with natural SP-D (dodecamers and higher order SP-D complexes) followed by recombinant dodecamers. In contrast, recombinant full-length trimers exhibit substantially less binding, which is similar to that observed with a recombinant truncated molecule consisting of the CRD and neck regions, and containing trimers of this portion of the molecule. Taken together, these findings strongly indicate that the CRD of SP-D mediates interaction with P. carinii gpA through its attached oligosaccharides and that the extent of SP-D binding to P. carinii is greatest with dodecamers and higher order forms of SP-D.
T H 2-Mediated Pulmonary Inflammation Leads to the Differential Expression of Ribonuclease Genes by Alveolar Macrophages
Cormier, Stephania A. , Yuan, Shubing, Crosby, Jeffrey R., Protheroe, Cheryl, Dimina, Dawn, Hines, Edith M., Lee, Nancy A., Lee, James J.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 27 | Issue: 6 | Pages: 678-687

10.1165/rcmb.4882 | PMID 12444027 Get It

Abstract The eosinophil-associated ribonuclease (Ear) family in the mouse consists of thirteen genes, eleven of which encode RNases that have physical/functional properties similar to the human Ears, eosinophil-derived neurotoxin and eosinophil cationic protein. The expression of Ear genes in the mouse is confined to sites of known eosinophilopoiesis, with the exception of the lung. Two Ear genes, Ear1 and Ear2, are predominantly expressed in the lungs of naive mice. Total Ear gene expression and RNase activity in bronchoalveolar lavage fluid increases significantly upon the induction of pulmonary inflammation using an ovalbumin (OVA) model of allergic sensitization and challenge. Interestingly, pulmonary Ear11 transcripts, which are absent in naive mice, accumulate as a consequence of OVA-mediated TH2 inflammation in the lung. The induction of Ear11 expression is dependent on the presence of T cells, in particular, CD4+ T lymphocytes. This effect is likely the result of the elaboration of TH2 cytokine levels, because pulmonary instillation of interleukin-4 or interleukin-13 induces the accumulation of Ear11 transcripts in naive animals. This study demonstrates that despite an allergen-mediated pulmonary eosinophilia and earlier studies showing that Ears are constituents of eosinophil secondary granules, alveolar macrophages are a significant source of these RNases in lungs of OVA-treated mice.
Understanding Nonspecific Interstitial Pneumonia: The Need for a Diagnostic Gold Standard
Colby, Thomas V. , Galvin, J R, Hunninghake, Gary, King, Talmadge E. , Lynch, David A. , Travis, William D.

American Journal of Respiratory and Critical Care Medicine | April 3, 2013 | Volume: 179 | Issue: 3 | Pages: 256-256

10.1164/ajrccm.179.3.256 Get It

Surgical Lung Biopsy in the Diagnosis of Idiopathic NSIP: Do We Always Need It in the Initial Approach?
Colby, Thomas V. , Galvin, J R, Hunninghake, Gary, King, Talmadge E. , Lynch, David A. , Travis, William D.

American Journal of Respiratory and Critical Care Medicine | April 3, 2013 | Volume: 179 | Issue: 11 | Pages: 1071-1072

10.1164/ajrccm.179.11.1071a | PMID 19458271 Get It

What predicts enduring intractability in children who appear medically intractable in the first 2 years after diagnosis?
Mandrekar, Jay , Nickels, Katherine , Wirrell, Elaine , Wong‐Kisiel, Lily C. , Nickels, Katherine C

Epilepsia | April 3, 2013 | Volume: 54 | Issue: 6 | Pages: 1056-1064

10.1111/epi.12169 | PMID 23551186 Get It

SummaryPurposeIn a population‐based retrospective cohort of children with newly diagnosed epilepsy, to determine (1) what proportion meet criteria for early medical intractability, and (2) predictors of enduring intractability.MethodsChildren with newly diagnosed epilepsy between 1980 and 2009 while resident in Olmsted County, MN, and followed >36 months, were stratified into groups based on both early medical intractability (“apparent” medical intractability in the first 2 years) and enduring intractability (persisting intractability at final follow‐up or having undergone surgery for intractable epilepsy), and variables predicting these outcomes were evaluated.Key FindingsThree hundred eighty‐one children were included, representing 81% of our cohort with newly diagnosed epilepsy. Seventy five (19.7%) had early medical intractability, and predictors of this outcome on multivariable analysis were neuroimaging abnormality (risk ratio, 2.70; p = 0.0004), abnormal neurologic examination at diagnosis (risk ratio, 1.87; p = 0.015), and mode of onset (association was significant for focal vs. generalized onset [risk ratio, 0.25; p < 0.0001] but not unknown vs. generalized onset [p = 0.065]). After a median follow‐up of 11.7 years, 49% remained intractable, 8% had rare seizures (≤ every 6 months), and the remainder were seizure‐free. The only factor predicting enduring intractability on multivariable analysis was neuroimaging abnormality (risk ratio, 7.0; p = 0.0006).SignificanceAlthough a significant minority of children with early medical intractability ultimately achieved seizure control without surgery, those with an abnormal imaging study did poorly. For this subgroup, early surgical intervention is strongly advised to limit comorbidities of ongoing, intractable seizures. Conversely, a cautious approach is suggested for those with normal imaging, as most will remit with time.
Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era
Choquet, Sylvain , Jagadeesh, Deepa , Smith, Sonali M. , Leblond, V., Roy, Rupali, Gordon, Leo I. , Dierickx, Daan , Schiff, David , Evens, Andrew M. , Kroll‐Desrosiers, Aimee , Morschhauser, Franck , BARTON, BRUCE A. , Gandhi, Maher K. , Habermann, Thomas M. , Trappe, Ralf Ulrich , Gordon, Leo I

American Journal of Transplantation | April 3, 2013 | Volume: No volume available | Issue: No issue available | Pages: n/a-n/a

10.1002/ajt.12211 Get It